Arylomycin A2: Uses, Mechanism & Lab FAQs

Arylomycin A2 is a naturally occurring lipoglycopeptide antibiotic that selectively inhibits bacterial type I signal peptidase (SPase I), making it a valuable tool compound for studying bacterial protein secretion and membrane biology.

Product Name

Arylomycin A2

SKU

A1420091

Compound Class

Lipoglycopeptide / cyclic depsipeptide antibiotic

Primary Target

Bacterial type I signal peptidase (SPase I)

Biological Activity

Inhibits SPase I, blocking cleavage of signal peptides from pre-proteins

Research Application

Antibacterial mechanism studies, SPase inhibitor tool compound, protein secretion research

What Is Arylomycin A2?

Arylomycin A2 is a member of the arylomycin family of naturally produced lipopeptide antibiotics, originally isolated from Streptomyces species. Structurally, it is characterized by a macrocyclic biaryl-bridged tripeptide core linked to a fatty acid chain and, in the glycosylated variant, a sugar moiety. The compound belongs to the broader class of cyclic depsipeptides and is closely related to Arylomycin A1 and the Arylomycin B series, differing mainly in the length and saturation of the N-terminal lipid tail.

Its significance in chemical biology stems from its potent and selective inhibition of bacterial type I signal peptidase (SPase I), an essential serine protease located on the outer leaflet of the bacterial cytoplasmic membrane. Because SPase I is required for the processing of virtually all secreted and membrane-anchored proteins, it represents a mechanistically validated antibacterial target.

Mechanism of Action

Arylomycin A2 acts as a non-covalent inhibitor of bacterial type I signal peptidase. SPase I is a serine-lysine dyad protease that cleaves the N-terminal signal peptide from pre-proteins as they are translocated across or inserted into the cytoplasmic membrane via the Sec or Tat pathways. By binding to the active site of SPase I, Arylomycin A2 competitively blocks substrate access, preventing signal peptide cleavage and causing lethal accumulation of unprocessed pre-proteins in the membrane.

Structural studies have shown that the biaryl-bridged macrocycle of arylomycins adopts a conformation that mimics the transition state of substrate binding, allowing the compound to interact with key catalytic and substrate-binding residues of SPase I. A single-point resistance mutation (Pro→Ser at a conserved position in SPase I) confers resistance in many laboratory strains, which has historically limited observed antibacterial potency; however, many clinically relevant pathogens lack this resistance mutation, underscoring the translational relevance of this scaffold.

Solubility, Storage & Handling

For optimal results, researchers should consult the Certificate of Analysis supplied with each lot of Arylomycin A2 (SKU: A1420091) for confirmed purity and recommended handling conditions. General guidance based on the chemical class is provided below; all critical parameters should be verified experimentally:

• Solubility: Arylomycins are generally soluble in DMSO. Aqueous solubility is limited; prepare stock solutions in DMSO and dilute into aqueous buffers immediately before use. Keep final DMSO concentrations ≤0.1% in cell-based or enzymatic assays unless solvent tolerance has been established.
• Storage: Store as a solid at –20 °C, protected from light and moisture. Avoid repeated freeze-thaw cycles of stock solutions.
• Stability: Peptide-based natural products can be susceptible to hydrolysis and oxidation; prepare fresh working solutions where possible.

Note: Specific solubility values and confirmed storage recommendations require verification against lot-specific data. This information is flagged for review.

Research Applications

Arylomycin A2 is primarily used as a biochemical tool compound in the following research contexts:

• SPase I inhibition assays: Used to validate and characterize the activity of signal peptidase enzymes from Gram-positive and Gram-negative bacteria, including fluorescence- and FRET-based peptide cleavage assays.
• Antibacterial mechanism studies: Serves as a reference compound to study SPase I as an antibacterial target, assess resistance mechanisms (e.g., the Pro→Ser mutation), and benchmark novel inhibitor scaffolds.
• Bacterial protein secretion research: Applied to dissect Sec- and Tat-dependent secretion pathways by pharmacologically blocking the terminal signal peptide processing step.
• Structure-activity relationship (SAR) studies: Used as a parent scaffold to evaluate semisynthetic arylomycin analogs with improved potency, spectrum, or pharmacokinetic properties.

Researchers investigating new-generation SPase I inhibitors as potential Gram-negative antibiotics have employed arylomycins as key reference standards in MIC determinations, enzyme kinetics, and X-ray co-crystallography studies.

Ordering & Product Information

Arylomycin A2 is available from Aladdin Scientific under SKU A1420091. For current pricing, available pack sizes, purity specifications, and lead times, please contact your Aladdin Scientific representative or visit the product page on our website. A Certificate of Analysis (CoA) is available for each manufactured lot upon request.

For bulk quantities, custom formulations, or questions regarding regulatory documentation (SDS, CoA), please reach out to our technical sales team. Aladdin Scientific is committed to providing research-grade reagents with full quality documentation to support your experimental needs.

Frequently asked questions

What is the primary mechanism of action of Arylomycin A2?

Arylomycin A2 inhibits bacterial type I signal peptidase (SPase I), a serine protease essential for cleaving N-terminal signal peptides from secreted pre-proteins. By blocking this cleavage step, the compound causes accumulation of unprocessed pre-proteins in the bacterial membrane, ultimately leading to cell death. It acts as a non-covalent, competitive inhibitor that mimics the substrate transition state.

Why do some bacterial strains show resistance to Arylomycin A2?

Many laboratory strains of bacteria carry a conserved proline residue in SPase I that is naturally replaced by serine, conferring intrinsic resistance to arylomycins by disrupting the compound's binding to the active site. This single amino acid difference (Pro→Ser substitution) significantly reduces inhibitor affinity. Importantly, numerous clinically relevant bacterial pathogens retain the proline residue and remain sensitive, which is why arylomycins continue to be actively studied as antibacterial leads.

In what solvents can Arylomycin A2 be dissolved for laboratory use?

Arylomycin A2 is generally soluble in DMSO, which is the recommended solvent for preparing concentrated stock solutions. Aqueous solubility is limited, so stocks should be prepared in DMSO and then diluted into the appropriate aqueous assay buffer immediately before use. Final DMSO concentrations in assays should be minimized (typically ≤0.1%) to avoid confounding effects. Researchers are advised to confirm solubility parameters from the lot-specific Certificate of Analysis provided by Aladdin Scientific.

What bacterial species or targets are most commonly studied using Arylomycin A2?

Arylomycin A2 has been used to study SPase I in both Gram-positive and Gram-negative bacteria. Research has focused particularly on pathogens such as Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa, where the compound serves as a tool to probe SPase I function and as a reference in antibacterial drug discovery programs. Its utility spans basic mechanistic studies of the Sec secretion pathway to translational efforts aimed at developing new-class antibiotics.

How should Arylomycin A2 (SKU A1420091) be stored to maintain stability?

As a peptide-derived natural product, Arylomycin A2 should be stored as a solid at –20 °C in a dry environment, protected from light and moisture. Repeated freeze-thaw cycles of dissolved stock solutions should be avoided; it is best practice to prepare single-use aliquots. Always verify storage conditions against the Certificate of Analysis provided with your specific lot (SKU A1420091) from Aladdin Scientific.

References

1. Paetzel M. Structure and mechanism of Escherichia coli signal peptidase I. Biochim Biophys Acta. 2014;1843(8):1497-1508. doi:10.1016/j.bbamcr.2013.12.003
2. Heinis C, et al. Natural product-inspired cyclic peptide inhibitors of signal peptidase I. Nat Chem Biol. (general reference placeholder — specific article details not confirmed from source material).
3. Kulanthaivel P, et al. Novel lipoglycopeptides as inhibitors of bacterial signal peptidase I. J Biol Chem. 2004;279(35):36250-36258.
4. Smith PA, et al. Optimized arylomycins are a new class of Gram-negative antibiotics. Nature. 2018;561(7722):189-194. doi:10.1038/s41586-018-0483-6

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.